Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 15 04:00PM ET
17.65
Dollar change
-0.20
Percentage change
-1.12
%
IndexNDX, S&P 500 P/E- EPS (ttm)-7.00 Insider Own17.51% Shs Outstand863.67M Perf Week-7.88%
Market Cap15.23B Forward P/E5.52 EPS next Y3.20 Insider Trans0.00% Shs Float711.62M Perf Month-14.40%
Income-6037.00M PEG- EPS next Q0.72 Inst Own59.54% Short Float4.95% Perf Quarter-24.15%
Sales144.60B P/S0.11 EPS this Y-18.79% Inst Trans-0.06% Short Ratio2.65 Perf Half Y-27.04%
Book/sh15.63 P/B1.13 EPS next Y-1.10% ROA-6.54% Short Interest35.22M Perf Year-50.67%
Cash/sh0.77 P/C22.79 EPS next 5Y-7.67% ROE-34.82% 52W Range17.70 - 36.14 Perf YTD-32.40%
Dividend Est.1.53 (8.65%) P/FCF- EPS past 5Y- ROI-13.79% 52W High-51.16% Beta0.78
Dividend TTM1.69 (9.58%) Quick Ratio0.32 Sales past 5Y1.35% Gross Margin16.90% 52W Low-0.28% ATR (14)0.68
Dividend Ex-DateFeb 16, 2024 Current Ratio0.66 EPS Y/Y TTM-92.32% Oper. Margin0.60% RSI (14)29.44 Volatility2.89% 3.39%
Employees331000 Debt/Eq2.57 Sales Y/Y TTM8.48% Profit Margin-4.18% Recom3.10 Target Price22.98
Option/ShortYes / Yes LT Debt/Eq2.25 EPS Q/Q-941.30% Payout- Rel Volume0.78 Prev Close17.85
Sales Surprise3.32% EPS Surprise46.57% Sales Q/Q6.28% EarningsMar 28 BMO Avg Volume13.29M Price17.65
SMA20-10.79% SMA50-15.74% SMA200-25.08% Trades Volume10,421,422 Change-1.12%
Date Action Analyst Rating Change Price Target Change
Feb-26-24Initiated Leerink Partners Market Perform $23
Feb-20-24Downgrade HSBC Securities Hold → Reduce
Jan-03-24Initiated Barclays Underweight $21
Dec-22-23Initiated HSBC Securities Hold $27
Oct-23-23Upgrade JP Morgan Neutral → Overweight $27 → $30
Jul-03-23Reiterated Morgan Stanley Underweight $37 → $27
Jun-28-23Downgrade Deutsche Bank Buy → Hold $46 → $34
Feb-23-23Initiated Loop Capital Buy $45
Nov-23-22Resumed Morgan Stanley Underweight $39
Nov-22-22Upgrade Cowen Market Perform → Outperform $43 → $54
Apr-15-24 06:31PM
08:00AM
Apr-12-24 12:56PM
Apr-11-24 05:34AM
Apr-10-24 04:42PM
09:53AM Loading…
09:53AM
07:45AM
Apr-09-24 03:38PM
10:45AM
Apr-07-24 05:35AM
03:00AM
Apr-04-24 01:44PM
09:00AM
08:40AM
Apr-03-24 01:48PM
11:34AM Loading…
11:34AM
08:45AM
Apr-02-24 10:45AM
Apr-01-24 05:29PM
04:34PM
03:47PM
12:38PM
01:11AM
Mar-31-24 02:17PM
08:35AM
Mar-30-24 01:00PM
Mar-29-24 04:54PM
12:29PM
01:01AM
12:35AM
07:46PM Loading…
Mar-28-24 07:46PM
07:40PM
06:44PM
04:49PM
04:39PM
04:37PM
04:35PM
04:19PM
03:24PM
02:48PM
01:06PM
01:06PM
12:50PM
12:18PM
11:53AM
11:34AM
11:32AM
11:24AM
11:06AM
10:54AM
10:47AM
10:38AM
10:06AM
09:43AM
09:32AM
09:30AM
08:38AM
08:31AM
08:21AM
08:15AM
08:10AM
08:02AM
07:20AM
07:20AM
07:10AM
07:07AM
07:07AM
07:00AM
Mar-27-24 05:05PM
04:30PM
Mar-26-24 11:18AM
10:35AM
06:05AM
Mar-25-24 12:09PM
11:26AM
09:15AM
Mar-24-24 02:00PM
10:58AM
07:56AM
Mar-23-24 05:43AM
Mar-22-24 05:45PM
04:31PM
07:37AM
Mar-21-24 05:50PM
12:37PM
10:00AM
08:30AM
06:16AM
Mar-20-24 01:23PM
08:15AM
Mar-18-24 06:00AM
05:55AM
01:00AM
Mar-15-24 05:45PM
10:05AM
Mar-14-24 01:41PM
09:26AM
09:00AM
Mar-13-24 01:15PM
08:37AM
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bhandari Inderpal SDirectorApr 11 '24Buy18.053,00054,1503,000Apr 15 05:45 PM
Mahajan ManmohanEVP and Global CFOApr 02 '24Buy19.386,000116,280166,969Apr 02 06:40 PM
Walgreens Boots Alliance, Inc.10% OwnerFeb 07 '24Sale235.414,212,395991,639,90726,277,561Feb 09 07:00 AM
JARRETT VALERIE BDirectorJan 29 '24Buy22.444,45699,9934,456Jan 31 04:11 PM
SCHLICHTING NANCY MDirectorJan 16 '24Sale23.0515,209350,5670Jan 18 04:18 PM
WENTWORTH TIMOTHY CChief Executive OfficerJan 05 '24Buy24.2210,000242,220585,122Jan 08 07:29 AM
Gates Richard P.SVP, Chief Pharmacy OfficerNov 10 '23Sale20.451,00020,45073,929Nov 14 08:22 PM
Walgreens Boots Alliance, Inc.10% OwnerNov 09 '23Sale195.381,279,590249,999,89630,489,956Nov 14 07:15 AM
Walgreens Boots Alliance, Inc.10% OwnerAug 03 '23Sale189.271,320,858250,000,11531,769,546Aug 07 05:48 PM
DRISCOLL JOHN PATRICKEVP, Pres. U.S. HealthcareJun 30 '23Buy28.425,172146,98459,050Jul 05 06:57 PM
Walgreens Boots Alliance, Inc.10% OwnerJun 15 '23Sale181.17275,98450,000,02133,090,404Jun 20 06:03 AM
Walgreens Boots Alliance, Inc.10% OwnerMay 11 '23Sale170.77292,79250,000,09033,366,388May 15 05:18 PM